Jump to content

Talk:David Zarling

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Untitled

[edit]

- I attended David Zarling's presentation at 5th annual cancer drugs R&D conference in Phoenix, Arizona (Feb 21-22). His new company has developed a set of drugs that hypothetically can help with even the latest stages of prostate cancer when it gets to the bone (6 months prognosis).

- I know about the diseases not only from textbooks and follow clinical trials of Synta and Cougar. Colby's drug candidates will probably have lower toxicity and higher efficacy then Synta's and Cougar's. I would like to enroll into early stage clinical prevention trials...

- I asked him for information on Colby, his scientists and himself, but since the company is in early stage, most of the data is confidential. He sent me his biography and I thought it would be worthwhile to put his profile onto Wikipedia.

- I work for GTCbio and volunteer at several institutions targeting diseases of aging. This article is not self promotion and any help with getting the message that Colby developed really potent prostate cancer therapeutics is much appreciated. There are many men that need hope.